evenfolio

Aditya Birla Sun Life Pharma and Healthcare Fund

NAV
₹39.28
—30 Oct 2026
AUM (₹ Cr)
1,076
Average, July - September 2026
Expense ratio
1.07%
Regular 2.29%
Risk
Very High
SEBI riskometer
3Y CAGR
21.1%-1.6%
Benchmark 22.7%
5Y CAGR
14.8%-0.6%
Benchmark 15.4%
Loading NAV history…
Aditya Birla Sun Life Pharma and Healthcare Fund

Rank in category

#6 of 8 Healthcare funds on its 1-, 3- and 5-year returns together.

Ranked on 1Y, 3Y and 5Y together. 8 of 19 funds have a rank here; it needs a 5-year record. Direct plan, growth option. Click a column to rank by it.

Calendar-year returns

Fund only: no comparison series covers this fund's history.

Risk statistics

Five years of daily NAVs. Risk-free rate 6.5% a year.

Standard deviation
—
Maximum drawdown
—
Sharpe ratio
—
Sortino ratio
—
Beta
—
Alpha
—
R²
—
Information ratio
—
Upside capture
—
Downside capture
—
Tracking error
—
Trailing returns compared with benchmark
Period1M3M6MYTD1Y3YCAGR5YCAGR10YCAGRLaunchCAGR
Fund-1.1%-3.1%+12.0%+15.9%+14.2%+21.1%+14.8%—+20.5%
BSE Healthcare TRI————10.8%22.7%15.4%—21.3%
Healthcare average-0.3%-0.9%13.5%16.7%14.5%22.4%16.1%14.7%16.3%
Difference————+3.3%-1.6%-0.6%—-0.8%

Portfolio

Valuation

P/E
41.9
Covers 96% of its shares
Category median
48.4
19 Healthcare funds
Benchmark P/E
44.3
BSE Healthcare

P/E is the value of the shares the fund holds, at the close of 30 Oct 2026, over their profit in the last four reported quarters (the owners' share from continuing operations, consolidated where filed, losses included), weighted by the fund's portfolio disclosed 19 Oct 2026. The category median is worked out the same way; the benchmark's is the index provider's own figure on the same basis.

Fund details

Fund house
Aditya Birla Sun Life Mutual Fund
Category
Equity · Healthcare
SEBI classification
Equity / Sectoral / Thematic
Benchmark
BSE Healthcare TRI
Launch date
11 Jul 2019 (7.3 years)
Structure
Open Ended
Plans and options
Direct Growth, Regular Growth
Fund manager
Dhaval Shah
Minimum SIP
₹100
Minimum lumpsum
₹1,000 (then ₹1,000)
Exit load
1.00%
Lock-in
None
Riskometer
Very High (benchmark Very High)
Expense ratio as of
28 Oct 2026
AUM period
July - September 2026
ISIN, Direct Growth
INF209KB1O25
ISIN, Regular Growth
INF209KB1N91
Scheme code
147409, 147407

NAV and returns as of 30 Oct 2026; returns are for the direct plan, growth option, before entry or exit costs. Not investment advice.

Other healthcare funds

Other funds in the Healthcare category.

Search

Search funds, ETFs, stocks, pages and tools